Asensus Surgical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	9.85	8.58	7.09	8.23	3.18	8.53
Revenue Growth (YoY)	39.05%	21.02%	-13.91%	159.28%	-62.78%	-64.60%
Cost of Revenue	12.85	13.16	10.87	11.1	5.17	13.33
Gross Profit	-3	-4.58	-3.79	-2.86	-1.99	-4.8
Selling, General & Admin	34.15	36.08	34.93	32.72	27.2	46.77
Research & Development	33.63	37.02	28.94	19.35	16.62	22.47
Operating Expenses	68.22	73.55	71.58	63.32	54.62	79.54
Operating Income	-71.22	-78.13	-75.36	-66.18	-56.61	-84.34
Interest Expense	-0.32	-	-0.41	-0.37	-0.02	-3.61
Interest & Investment Income	0.88	1.55	1.14	0.59	0.04	0.58
Other Non Operating Income (Expenses)	0.44	-0.2	-0.3	-2	-0.46	1.28
EBT Excluding Unusual Items	-70.23	-76.78	-74.93	-67.96	-57.05	-86.09
Merger & Restructuring Charges	-	-	-	-	-0.85	-8.77
Impairment of Goodwill	-	-	-	-	-	-78.97
Gain (Loss) on Sale of Assets	-	-	-	-	-	15.87
Asset Writedown	-0.37	-0.37	-1.43	-	-	-
Other Unusual Items	-12.84	-0.96	1.12	5.72	-2.92	8.55
Pretax Income	-83.44	-78.12	-75.24	-62.24	-60.83	-157.33
Income Tax Expense	0.36	0.31	0.32	0.23	-1.52	-3.12
Net Income	-83.8	-78.43	-75.56	-62.46	-59.31	-154.2
Preferred Dividends & Other Adjustments	-	-	-	-	0.71	-
Net Income to Common	-83.8	-78.43	-75.56	-62.46	-60.02	-154.2
Shares Outstanding (Basic)	266	250	236	227	71	18
Shares Outstanding (Diluted)	266	250	236	227	71	18
Shares Change (YoY)	11.67%	5.58%	4.20%	220.52%	299.22%	11.29%
EPS (Basic)	-0.32	-0.31	-0.32	-0.28	-0.85	-8.69
EPS (Diluted)	-0.32	-0.31	-0.32	-0.28	-0.85	-8.69
Free Cash Flow	-57.16	-64.19	-60.22	-42.03	-46.68	-73.92
Free Cash Flow Per Share	-0.22	-0.26	-0.25	-0.19	-0.66	-4.17
Gross Margin	-30.45%	-53.38%	-53.41%	-34.79%	-62.71%	-56.27%
Operating Margin	-723.08%	-910.92%	-1063.40%	-803.98%	-1783.12%	-988.64%
Profit Margin	-850.75%	-914.46%	-1066.19%	-758.77%	-1890.49%	-1807.54%
Free Cash Flow Margin	-580.27%	-748.37%	-849.67%	-510.53%	-1470.17%	-866.50%
EBITDA	-67.47	-74.4	-64.29	-52.07	-42.92	-71.87
D&A For EBITDA	3.76	3.73	11.08	14.11	13.7	12.47
EBIT	-71.22	-78.13	-75.36	-66.18	-56.61	-84.34
Revenue as Reported	9.85	8.58	7.09	8.23	3.18	8.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q